

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.49760512 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.49760512 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.45360107 |
| 4 | response to peptidoglycan (GO:0032494) | 4.74600291 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 4.56060314 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.38466899 |
| 7 | type I interferon signaling pathway (GO:0060337) | 4.32777809 |
| 8 | cellular response to type I interferon (GO:0071357) | 4.32777809 |
| 9 | response to type I interferon (GO:0034340) | 4.29517596 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.28954631 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.28954631 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.28954631 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.28954631 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.28954631 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.28954631 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 4.26888019 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.24084806 |
| 18 | positive regulation of interferon-alpha production (GO:0032727) | 4.19789797 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 4.18271345 |
| 20 | positive regulation of antigen processing and presentation (GO:0002579) | 4.06312534 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 3.99946521 |
| 22 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.98453778 |
| 23 | negative regulation of viral genome replication (GO:0045071) | 3.97933135 |
| 24 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.96773375 |
| 25 | response to interferon-alpha (GO:0035455) | 3.94243589 |
| 26 | regulation of RIG-I signaling pathway (GO:0039535) | 3.86152574 |
| 27 | defense response to protozoan (GO:0042832) | 3.83680232 |
| 28 | leukocyte aggregation (GO:0070486) | 3.80540249 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.80375252 |
| 30 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.79289970 |
| 31 | response to interferon-beta (GO:0035456) | 3.78632171 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.77383670 |
| 33 | detection of external biotic stimulus (GO:0098581) | 3.77169185 |
| 34 | superoxide anion generation (GO:0042554) | 3.75669076 |
| 35 | regulation of activation of Janus kinase activity (GO:0010533) | 3.73732672 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.72957399 |
| 37 | NIK/NF-kappaB signaling (GO:0038061) | 3.71547050 |
| 38 | neutrophil activation (GO:0042119) | 3.66133831 |
| 39 | granulocyte activation (GO:0036230) | 3.66030629 |
| 40 | cellular response to interferon-beta (GO:0035458) | 3.63295926 |
| 41 | immunoglobulin mediated immune response (GO:0016064) | 3.59203973 |
| 42 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.59187174 |
| 43 | cellular extravasation (GO:0045123) | 3.59062710 |
| 44 | positive regulation of interleukin-12 production (GO:0032735) | 3.54039825 |
| 45 | regulation of antigen processing and presentation (GO:0002577) | 3.50490197 |
| 46 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.50312195 |
| 47 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.50312195 |
| 48 | microglial cell activation (GO:0001774) | 3.49915505 |
| 49 | response to protozoan (GO:0001562) | 3.49555534 |
| 50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.49203081 |
| 51 | myeloid dendritic cell activation (GO:0001773) | 3.49061134 |
| 52 | response to interleukin-15 (GO:0070672) | 3.47031551 |
| 53 | response to muramyl dipeptide (GO:0032495) | 3.46230124 |
| 54 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45153706 |
| 55 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.44696793 |
| 56 | response to host immune response (GO:0052572) | 3.44696793 |
| 57 | positive regulation of type 2 immune response (GO:0002830) | 3.44349116 |
| 58 | myeloid dendritic cell differentiation (GO:0043011) | 3.42958408 |
| 59 | respiratory burst (GO:0045730) | 3.39952594 |
| 60 | macrophage activation involved in immune response (GO:0002281) | 3.38793275 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.37455176 |
| 62 | regulation of regulatory T cell differentiation (GO:0045589) | 3.35974506 |
| 63 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.35876550 |
| 64 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.35673965 |
| 65 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.35574034 |
| 66 | regulation of chemokine biosynthetic process (GO:0045073) | 3.35572373 |
| 67 | positive regulation of heat generation (GO:0031652) | 3.31407220 |
| 68 | positive regulation of interleukin-17 production (GO:0032740) | 3.30255589 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 3.29027911 |
| 70 | detection of biotic stimulus (GO:0009595) | 3.28789420 |
| 71 | T-helper 1 type immune response (GO:0042088) | 3.27340220 |
| 72 | cellular response to interleukin-15 (GO:0071350) | 3.26277505 |
| 73 | macrophage activation (GO:0042116) | 3.24211412 |
| 74 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.24004717 |
| 75 | positive thymic T cell selection (GO:0045059) | 3.23816828 |
| 76 | regulation of tolerance induction (GO:0002643) | 3.23647511 |
| 77 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.23322938 |
| 78 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.22577640 |
| 79 | detection of other organism (GO:0098543) | 3.21291779 |
| 80 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20753616 |
| 81 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.20293531 |
| 82 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.19070181 |
| 83 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.18600977 |
| 84 | positive regulation of interferon-beta production (GO:0032728) | 3.18208398 |
| 85 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.15064891 |
| 86 | positive regulation of B cell differentiation (GO:0045579) | 3.14574947 |
| 87 | cellular response to exogenous dsRNA (GO:0071360) | 3.14182307 |
| 88 | negative T cell selection (GO:0043383) | 3.13329581 |
| 89 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.13043684 |
| 90 | regulation of fever generation (GO:0031620) | 3.13017939 |
| 91 | detection of molecule of bacterial origin (GO:0032490) | 3.12065051 |
| 92 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.11993181 |
| 93 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.11720679 |
| 94 | myeloid cell activation involved in immune response (GO:0002275) | 3.11387460 |
| 95 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.11329701 |
| 96 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.10944470 |
| 97 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.09904764 |
| 98 | negative thymic T cell selection (GO:0045060) | 3.08813871 |
| 99 | B cell receptor signaling pathway (GO:0050853) | 3.08474177 |
| 100 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.05957984 |
| 101 | response to host (GO:0075136) | 3.05957984 |
| 102 | response to host defenses (GO:0052200) | 3.05957984 |
| 103 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.05180468 |
| 104 | regulation of interleukin-17 production (GO:0032660) | 3.02930164 |
| 105 | monocyte chemotaxis (GO:0002548) | 3.02145452 |
| 106 | positive regulation of tolerance induction (GO:0002645) | 3.01965470 |
| 107 | dendritic cell chemotaxis (GO:0002407) | 3.01174237 |
| 108 | regulation of mast cell degranulation (GO:0043304) | 3.00903467 |
| 109 | reactive oxygen species biosynthetic process (GO:1903409) | 2.99320432 |
| 110 | neutrophil mediated immunity (GO:0002446) | 2.96499163 |
| 111 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.96477637 |
| 112 | dendritic cell differentiation (GO:0097028) | 2.95239055 |
| 113 | germinal center formation (GO:0002467) | 2.94784267 |
| 114 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.94713217 |
| 115 | natural killer cell mediated immunity (GO:0002228) | 2.94713217 |
| 116 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.94704829 |
| 117 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.94299029 |
| 118 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.93838575 |
| 119 | regulation of B cell differentiation (GO:0045577) | 2.92489263 |
| 120 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.92080186 |
| 121 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.92080186 |
| 122 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.91848397 |
| 123 | regulation of interleukin-12 production (GO:0032655) | 2.90062207 |
| 124 | detection of bacterium (GO:0016045) | 2.88902675 |
| 125 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.88674044 |
| 126 | negative regulation of innate immune response (GO:0045824) | 2.87999927 |
| 127 | tolerance induction (GO:0002507) | 2.87611429 |
| 128 | positive T cell selection (GO:0043368) | 2.87575175 |
| 129 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.86694098 |
| 130 | T cell migration (GO:0072678) | 2.86150039 |
| 131 | B cell mediated immunity (GO:0019724) | 2.85835545 |
| 132 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.85693747 |
| 133 | positive regulation of defense response to virus by host (GO:0002230) | 2.85622717 |
| 134 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.85485433 |
| 135 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.84883041 |
| 136 | cellular response to zinc ion (GO:0071294) | 2.84352615 |
| 137 | positive regulation of interleukin-10 production (GO:0032733) | 2.84234105 |
| 138 | negative regulation of interleukin-17 production (GO:0032700) | 2.84114664 |
| 139 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.84048647 |
| 140 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.84048647 |
| 141 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.84023055 |
| 142 | myeloid leukocyte activation (GO:0002274) | 2.83680488 |
| 143 | regulation of immunoglobulin secretion (GO:0051023) | 2.83403195 |
| 144 | regulation of mast cell activation (GO:0033003) | 2.83397951 |
| 145 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78839575 |
| 146 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.77988186 |
| 147 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77542551 |
| 148 | leukocyte degranulation (GO:0043299) | 2.77021679 |
| 149 | cellular response to interferon-gamma (GO:0071346) | 2.75628847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.39783115 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.22919023 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.82500225 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.11861248 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.92951953 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.36430327 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.93156058 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.63357208 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63329600 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16680543 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.14006126 |
| 12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.01822403 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.00390774 |
| 14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.99549799 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.96705008 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.75560124 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.56438732 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.51213665 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.20902226 |
| 20 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.13665141 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.07333805 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02136508 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.89196719 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.84235490 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70176395 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68779433 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.68726958 |
| 28 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.65880698 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.64723805 |
| 30 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.64145100 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62330239 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57565741 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.56079731 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53812560 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53574228 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.53180006 |
| 37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.48854885 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47701105 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46556178 |
| 40 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43546224 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41293570 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39932807 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.38605531 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37758743 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34379716 |
| 46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.32942524 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32597757 |
| 48 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32293084 |
| 49 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.31904893 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31080807 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.30930187 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.29723779 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27861909 |
| 54 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21714929 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19107357 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17649592 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17045881 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.14985556 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14696675 |
| 60 | MAF_26560356_Chip-Seq_TH1_Human | 1.13023101 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12922738 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12017126 |
| 63 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11466890 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.10389450 |
| 65 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09527008 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07502739 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07502049 |
| 68 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07405083 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07359526 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05856571 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05479212 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03731851 |
| 73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.03455206 |
| 74 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03171108 |
| 75 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03019952 |
| 76 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02845345 |
| 77 | MYC_22102868_ChIP-Seq_BL_Human | 1.00470525 |
| 78 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00049027 |
| 79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99510764 |
| 80 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99171532 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98663709 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98499328 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94979558 |
| 84 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93635343 |
| 85 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93553526 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93205656 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93091016 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93011806 |
| 89 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90042197 |
| 90 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.89440070 |
| 91 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.89369967 |
| 92 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88819729 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88819729 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88717802 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86403424 |
| 96 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84913356 |
| 97 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.83951803 |
| 98 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.83671737 |
| 99 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.83509652 |
| 100 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82789190 |
| 101 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82785927 |
| 102 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81891034 |
| 103 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.80980879 |
| 104 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.80813469 |
| 105 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79880557 |
| 106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79270383 |
| 107 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78651941 |
| 108 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78467768 |
| 109 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78344687 |
| 110 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.78268068 |
| 111 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77876257 |
| 112 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.77692165 |
| 113 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.76898547 |
| 114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76765126 |
| 115 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76724764 |
| 116 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76364286 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76144559 |
| 118 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.76118002 |
| 119 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.74458094 |
| 120 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.73286832 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72989303 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72989303 |
| 123 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.72610272 |
| 124 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.72574819 |
| 125 | CJUN_26792858_Chip-Seq_BT549_Human | 0.72248356 |
| 126 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.71724993 |
| 127 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.71597253 |
| 128 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.70716563 |
| 129 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.70608753 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69980550 |
| 131 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.69507305 |
| 132 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.67923770 |
| 133 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.67844800 |
| 134 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.67401430 |
| 135 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.66257213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.95384702 |
| 2 | MP0009785_altered_susceptibility_to | 4.20217607 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.78642366 |
| 4 | MP0000685_abnormal_immune_system | 3.57610715 |
| 5 | MP0003724_increased_susceptibility_to | 3.53598389 |
| 6 | MP0003436_decreased_susceptibility_to | 3.39462827 |
| 7 | MP0005671_abnormal_response_to | 3.18833067 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.14290262 |
| 9 | MP0001790_abnormal_immune_system | 3.13142761 |
| 10 | MP0005387_immune_system_phenotype | 3.13142761 |
| 11 | MP0005025_abnormal_response_to | 3.09642117 |
| 12 | MP0006082_CNS_inflammation | 3.06991397 |
| 13 | MP0002419_abnormal_innate_immunity | 2.99542291 |
| 14 | MP0001800_abnormal_humoral_immune | 2.73357465 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.70842590 |
| 16 | * MP0002723_abnormal_immune_serum | 2.58739712 |
| 17 | MP0001819_abnormal_immune_cell | 2.35008704 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.31615681 |
| 19 | MP0004510_myositis | 2.13354767 |
| 20 | MP0009764_decreased_sensitivity_to | 2.06265141 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.01088279 |
| 22 | MP0010155_abnormal_intestine_physiology | 1.99730456 |
| 23 | MP0002254_reproductive_system_inflammat | 1.94376264 |
| 24 | MP0001853_heart_inflammation | 1.92661095 |
| 25 | MP0002405_respiratory_system_inflammati | 1.89622620 |
| 26 | MP0004947_skin_inflammation | 1.87782094 |
| 27 | MP0002006_tumorigenesis | 1.86312406 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.83020057 |
| 29 | * MP0001845_abnormal_inflammatory_respons | 1.82721438 |
| 30 | MP0003303_peritoneal_inflammation | 1.82576124 |
| 31 | MP0000716_abnormal_immune_system | 1.72763365 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.67984940 |
| 33 | MP0002398_abnormal_bone_marrow | 1.67901857 |
| 34 | MP0003763_abnormal_thymus_physiology | 1.66585713 |
| 35 | MP0009278_abnormal_bone_marrow | 1.60284230 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.59751431 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.59751431 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.56168204 |
| 39 | MP0005310_abnormal_salivary_gland | 1.56040055 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.55537173 |
| 41 | MP0003448_altered_tumor_morphology | 1.51447152 |
| 42 | * MP0008469_abnormal_protein_level | 1.51025854 |
| 43 | MP0005451_abnormal_body_composition | 1.43711031 |
| 44 | MP0000343_altered_response_to | 1.41170107 |
| 45 | MP0002429_abnormal_blood_cell | 1.36354486 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.35997606 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.35779119 |
| 48 | MP0001873_stomach_inflammation | 1.35328896 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.34046378 |
| 50 | MP0004782_abnormal_surfactant_physiolog | 1.31462598 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.31149631 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.27995493 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.27792407 |
| 54 | MP0000858_altered_metastatic_potential | 1.27348241 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.27257543 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.25568545 |
| 57 | MP0004883_abnormal_blood_vessel | 1.25539285 |
| 58 | MP0002722_abnormal_immune_system | 1.23161759 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.20151248 |
| 60 | MP0003075_altered_response_to | 1.18915401 |
| 61 | MP0003828_pulmonary_edema | 1.11354551 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.11335903 |
| 63 | MP0006054_spinal_hemorrhage | 1.08538886 |
| 64 | MP0004381_abnormal_hair_follicle | 1.08384459 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.00109825 |
| 66 | MP0005390_skeleton_phenotype | 0.99996835 |
| 67 | MP0005166_decreased_susceptibility_to | 0.97342303 |
| 68 | MP0005164_abnormal_response_to | 0.96157710 |
| 69 | MP0009763_increased_sensitivity_to | 0.95341082 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 0.94832478 |
| 71 | MP0000604_amyloidosis | 0.92873365 |
| 72 | MP0003300_gastrointestinal_ulcer | 0.91365683 |
| 73 | MP0000015_abnormal_ear_pigmentation | 0.90494379 |
| 74 | MP0001346_abnormal_lacrimal_gland | 0.89712500 |
| 75 | MP0003186_abnormal_redox_activity | 0.89453100 |
| 76 | MP0002933_joint_inflammation | 0.89091973 |
| 77 | MP0009840_abnormal_foam_cell | 0.88973151 |
| 78 | MP0001348_abnormal_lacrimal_gland | 0.88920897 |
| 79 | MP0000490_abnormal_crypts_of | 0.88524534 |
| 80 | MP0001851_eye_inflammation | 0.85677487 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.85115276 |
| 82 | MP0002132_abnormal_respiratory_system | 0.84914114 |
| 83 | MP0003183_abnormal_peptide_metabolism | 0.83598076 |
| 84 | MP0002332_abnormal_exercise_endurance | 0.80674536 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.80492741 |
| 86 | MP0000703_abnormal_thymus_morphology | 0.80483621 |
| 87 | MP0003866_abnormal_defecation | 0.79928740 |
| 88 | MP0003690_abnormal_glial_cell | 0.79230219 |
| 89 | MP0010307_abnormal_tumor_latency | 0.78426492 |
| 90 | MP0000371_diluted_coat_color | 0.77895938 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.75002694 |
| 92 | MP0003045_fibrosis | 0.72445466 |
| 93 | MP0008260_abnormal_autophagy | 0.71363090 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.69993473 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.67619336 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.67059999 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.67050391 |
| 98 | MP0003091_abnormal_cell_migration | 0.65829389 |
| 99 | MP0001879_abnormal_lymphatic_vessel | 0.62230307 |
| 100 | MP0003252_abnormal_bile_duct | 0.61912439 |
| 101 | MP0002163_abnormal_gland_morphology | 0.61470306 |
| 102 | MP0000249_abnormal_blood_vessel | 0.61402889 |
| 103 | MP0005165_increased_susceptibility_to | 0.59695840 |
| 104 | MP0008874_decreased_physiological_sensi | 0.59544238 |
| 105 | MP0005023_abnormal_wound_healing | 0.58218231 |
| 106 | MP0001191_abnormal_skin_condition | 0.57738905 |
| 107 | MP0001881_abnormal_mammary_gland | 0.57677400 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 0.56937707 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.56760424 |
| 110 | MP0003795_abnormal_bone_structure | 0.56378251 |
| 111 | MP0001501_abnormal_sleep_pattern | 0.56317290 |
| 112 | MP0001663_abnormal_digestive_system | 0.54946461 |
| 113 | MP0010352_gastrointestinal_tract_polyps | 0.54904483 |
| 114 | MP0000767_abnormal_smooth_muscle | 0.53656079 |
| 115 | MP0000609_abnormal_liver_physiology | 0.53467831 |
| 116 | MP0008004_abnormal_stomach_pH | 0.53151523 |
| 117 | MP0003943_abnormal_hepatobiliary_system | 0.51982495 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.51090163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.30225000 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.99051596 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.60853573 |
| 4 | Mediastinal lymphadenopathy (HP:0100721) | 4.72866879 |
| 5 | Myositis (HP:0100614) | 4.62411484 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.53947200 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.53495621 |
| 8 | Optic neuritis (HP:0100653) | 4.47275457 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.47275457 |
| 10 | Orchitis (HP:0100796) | 4.47048937 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 4.32653865 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.24383311 |
| 13 | Increased IgM level (HP:0003496) | 4.10324479 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.09073540 |
| 15 | Recurrent skin infections (HP:0001581) | 3.80323769 |
| 16 | Vasculitis (HP:0002633) | 3.78088383 |
| 17 | Gingivitis (HP:0000230) | 3.59770725 |
| 18 | Prostate neoplasm (HP:0100787) | 3.56862499 |
| 19 | Stomatitis (HP:0010280) | 3.54891889 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.50036676 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.50036676 |
| 22 | Obstructive lung disease (HP:0006536) | 3.32419211 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.32419211 |
| 24 | Recurrent viral infections (HP:0004429) | 3.30659407 |
| 25 | Chronic otitis media (HP:0000389) | 3.20987941 |
| 26 | Pulmonary infiltrates (HP:0002113) | 3.17607539 |
| 27 | Periodontitis (HP:0000704) | 3.16533905 |
| 28 | Basal ganglia calcification (HP:0002135) | 3.16219922 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 3.15311455 |
| 30 | Cellulitis (HP:0100658) | 3.04795915 |
| 31 | Meningitis (HP:0001287) | 3.02610906 |
| 32 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.99406045 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.99406045 |
| 34 | Abnormality of glycolipid metabolism (HP:0010969) | 2.99406045 |
| 35 | Hypergammaglobulinemia (HP:0010702) | 2.97255030 |
| 36 | Pustule (HP:0200039) | 2.93560506 |
| 37 | Keratoconjunctivitis (HP:0001096) | 2.91325599 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.90064834 |
| 39 | Chest pain (HP:0100749) | 2.89123457 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.87438352 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 2.84869867 |
| 42 | Recurrent pneumonia (HP:0006532) | 2.82632041 |
| 43 | Abnormality of the prostate (HP:0008775) | 2.78407437 |
| 44 | Arterial thrombosis (HP:0004420) | 2.73935911 |
| 45 | Eosinophilia (HP:0001880) | 2.69324461 |
| 46 | Keratoconjunctivitis sicca (HP:0001097) | 2.69208411 |
| 47 | Hemoptysis (HP:0002105) | 2.67615912 |
| 48 | Leukocytosis (HP:0001974) | 2.64838823 |
| 49 | Osteomyelitis (HP:0002754) | 2.63759487 |
| 50 | Gingival bleeding (HP:0000225) | 2.62961181 |
| 51 | Pulmonary embolism (HP:0002204) | 2.59991990 |
| 52 | Peritonitis (HP:0002586) | 2.58290165 |
| 53 | Recurrent lower respiratory tract infections (HP:0002783) | 2.54891457 |
| 54 | Petechiae (HP:0000967) | 2.53014792 |
| 55 | Agammaglobulinemia (HP:0004432) | 2.52943281 |
| 56 | Urticaria (HP:0001025) | 2.52622418 |
| 57 | Recurrent bronchitis (HP:0002837) | 2.50291985 |
| 58 | Thrombocytosis (HP:0001894) | 2.49671241 |
| 59 | Tetraparesis (HP:0002273) | 2.46790008 |
| 60 | Thick nail (HP:0001805) | 2.45996113 |
| 61 | Autoimmune hemolytic anemia (HP:0001890) | 2.43967335 |
| 62 | Abnormality of B cell number (HP:0010975) | 2.43780537 |
| 63 | Granulocytopenia (HP:0001913) | 2.39694195 |
| 64 | Premature loss of primary teeth (HP:0006323) | 2.38898980 |
| 65 | Abnormality of eosinophils (HP:0001879) | 2.37899897 |
| 66 | Episodic fever (HP:0001954) | 2.36908706 |
| 67 | Amyloidosis (HP:0011034) | 2.36249219 |
| 68 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.35113474 |
| 69 | Abnormality of T cell number (HP:0011839) | 2.33288495 |
| 70 | Abnormality of T cell physiology (HP:0011840) | 2.32566335 |
| 71 | IgA deficiency (HP:0002720) | 2.25879592 |
| 72 | IgG deficiency (HP:0004315) | 2.25029718 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.24868755 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.24013081 |
| 75 | Joint swelling (HP:0001386) | 2.23796690 |
| 76 | Increased serum ferritin (HP:0003281) | 2.23308543 |
| 77 | Abnormality of T cells (HP:0002843) | 2.21995692 |
| 78 | Increased IgE level (HP:0003212) | 2.21572581 |
| 79 | Encephalitis (HP:0002383) | 2.18507697 |
| 80 | Chronic diarrhea (HP:0002028) | 2.18121654 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.16966986 |
| 82 | Abnormality of the pericardium (HP:0001697) | 2.16554500 |
| 83 | Cheilitis (HP:0100825) | 2.16005845 |
| 84 | Abnormality of the peritoneum (HP:0002585) | 2.13365783 |
| 85 | Hypochromic anemia (HP:0001931) | 2.13292620 |
| 86 | Gastrointestinal stroma tumor (HP:0100723) | 2.12920305 |
| 87 | Spontaneous hematomas (HP:0007420) | 2.11572384 |
| 88 | IgM deficiency (HP:0002850) | 2.10562413 |
| 89 | B lymphocytopenia (HP:0010976) | 2.09827528 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 2.09287990 |
| 91 | Increased cerebral lipofuscin (HP:0011813) | 2.08964968 |
| 92 | Epistaxis (HP:0000421) | 2.08827474 |
| 93 | Vertebral compression fractures (HP:0002953) | 2.07696918 |
| 94 | Loss of speech (HP:0002371) | 2.07686825 |
| 95 | Abnormality of the pleura (HP:0002103) | 2.07501300 |
| 96 | Panhypogammaglobulinemia (HP:0003139) | 2.06967165 |
| 97 | Porencephaly (HP:0002132) | 2.06740738 |
| 98 | Prolonged bleeding time (HP:0003010) | 2.06250412 |
| 99 | Alveolar cell carcinoma (HP:0006519) | 2.06029635 |
| 100 | Thyroiditis (HP:0100646) | 2.05440776 |
| 101 | Severe combined immunodeficiency (HP:0004430) | 2.04232094 |
| 102 | Sepsis (HP:0100806) | 2.03601442 |
| 103 | Inflammation of the large intestine (HP:0002037) | 2.03037504 |
| 104 | Colitis (HP:0002583) | 2.02772200 |
| 105 | Acute hepatic failure (HP:0006554) | 2.02028538 |
| 106 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.01914973 |
| 107 | Polyneuropathy (HP:0001271) | 2.00552580 |
| 108 | Skin rash (HP:0000988) | 2.00441921 |
| 109 | Gangrene (HP:0100758) | 1.99408797 |
| 110 | Anorexia (HP:0002039) | 1.98675399 |
| 111 | Vertigo (HP:0002321) | 1.97649525 |
| 112 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.97416905 |
| 113 | Lymphopenia (HP:0001888) | 1.96265302 |
| 114 | Arthralgia (HP:0002829) | 1.96217503 |
| 115 | Purpura (HP:0000979) | 1.95585692 |
| 116 | Reduced antithrombin III activity (HP:0001976) | 1.95089793 |
| 117 | Skin ulcer (HP:0200042) | 1.93024115 |
| 118 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.92447808 |
| 119 | Hematochezia (HP:0002573) | 1.92296457 |
| 120 | T lymphocytopenia (HP:0005403) | 1.90305595 |
| 121 | Chronic sinusitis (HP:0011109) | 1.89726539 |
| 122 | Glomerulopathy (HP:0100820) | 1.89296415 |
| 123 | Chromsome breakage (HP:0040012) | 1.86695121 |
| 124 | Keratitis (HP:0000491) | 1.86247539 |
| 125 | Albinism (HP:0001022) | 1.85974676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.37048155 |
| 2 | IRAK4 | 3.63174721 |
| 3 | IRAK3 | 3.27384670 |
| 4 | TXK | 3.03253794 |
| 5 | IKBKE | 3.02470495 |
| 6 | TBK1 | 2.99146015 |
| 7 | JAK3 | 2.88151681 |
| 8 | TYK2 | 2.78963655 |
| 9 | IKBKB | 2.60010302 |
| 10 | RIPK4 | 2.52817972 |
| 11 | KIT | 2.44636414 |
| 12 | MAP4K1 | 2.31322809 |
| 13 | BLK | 2.09281824 |
| 14 | GRK6 | 1.99176954 |
| 15 | PIM2 | 1.98921679 |
| 16 | JAK1 | 1.98434992 |
| 17 | TEC | 1.82894316 |
| 18 | MAP3K13 | 1.81438946 |
| 19 | EPHA3 | 1.75916627 |
| 20 | CHUK | 1.75546480 |
| 21 | PBK | 1.74390895 |
| 22 | BMPR2 | 1.72915528 |
| 23 | NLK | 1.66625731 |
| 24 | FGR | 1.62119004 |
| 25 | EIF2AK2 | 1.59146762 |
| 26 | BTK | 1.57711834 |
| 27 | BMPR1B | 1.49819794 |
| 28 | SYK | 1.46272098 |
| 29 | NME2 | 1.40584357 |
| 30 | SIK3 | 1.38266590 |
| 31 | ZAP70 | 1.36740375 |
| 32 | PRPF4B | 1.30112183 |
| 33 | TESK2 | 1.27172050 |
| 34 | EPHB1 | 1.25267414 |
| 35 | FGFR4 | 1.24084183 |
| 36 | ERN1 | 1.20682402 |
| 37 | HCK | 1.20681429 |
| 38 | IRAK1 | 1.19646057 |
| 39 | MAP3K11 | 1.17398673 |
| 40 | FGFR3 | 1.15893829 |
| 41 | PIM1 | 1.12966603 |
| 42 | MATK | 1.12711221 |
| 43 | MST4 | 1.09901028 |
| 44 | LYN | 1.08899699 |
| 45 | TAOK3 | 1.07679436 |
| 46 | YES1 | 1.05503581 |
| 47 | CSF1R | 1.05038531 |
| 48 | MAP3K1 | 1.04446415 |
| 49 | NEK9 | 1.03057502 |
| 50 | CSK | 1.01468557 |
| 51 | LCK | 1.00101967 |
| 52 | TGFBR2 | 0.99242959 |
| 53 | TAOK1 | 0.95569151 |
| 54 | ADRBK2 | 0.93230059 |
| 55 | ERBB3 | 0.92789115 |
| 56 | ZAK | 0.91474549 |
| 57 | TNIK | 0.91308676 |
| 58 | TGFBR1 | 0.88457918 |
| 59 | TRPM7 | 0.87817555 |
| 60 | MUSK | 0.87522989 |
| 61 | FLT3 | 0.86000233 |
| 62 | PTK2B | 0.79492921 |
| 63 | RPS6KA4 | 0.77601297 |
| 64 | NUAK1 | 0.77539864 |
| 65 | JAK2 | 0.73841603 |
| 66 | PIK3CG | 0.72676815 |
| 67 | TIE1 | 0.72470465 |
| 68 | KDR | 0.70302988 |
| 69 | PDK1 | 0.69764209 |
| 70 | LRRK2 | 0.67931759 |
| 71 | ITK | 0.67311281 |
| 72 | CDC42BPA | 0.65068430 |
| 73 | MAP2K3 | 0.64232168 |
| 74 | CAMKK2 | 0.64033850 |
| 75 | FES | 0.62393182 |
| 76 | PRKCD | 0.62101122 |
| 77 | MAP3K3 | 0.61969792 |
| 78 | MAP2K6 | 0.60840431 |
| 79 | FYN | 0.59059225 |
| 80 | MAP3K6 | 0.57683271 |
| 81 | MST1R | 0.55519798 |
| 82 | MOS | 0.54778482 |
| 83 | MAP3K2 | 0.53831690 |
| 84 | PDPK1 | 0.52723030 |
| 85 | RIPK1 | 0.52488259 |
| 86 | STK4 | 0.51938072 |
| 87 | ABL1 | 0.51886900 |
| 88 | PLK4 | 0.51413978 |
| 89 | CLK1 | 0.50438236 |
| 90 | KSR2 | 0.49948833 |
| 91 | GRK7 | 0.46418672 |
| 92 | TAOK2 | 0.46375989 |
| 93 | BMX | 0.44656098 |
| 94 | FRK | 0.44371929 |
| 95 | PRKCQ | 0.43751509 |
| 96 | MAPKAPK2 | 0.43492897 |
| 97 | GRK1 | 0.42356518 |
| 98 | MARK3 | 0.42296510 |
| 99 | MAP3K5 | 0.41378083 |
| 100 | MAPK11 | 0.39720203 |
| 101 | PRKG2 | 0.39119160 |
| 102 | PTK6 | 0.37865685 |
| 103 | MAPK7 | 0.37620805 |
| 104 | ACVR1B | 0.37605891 |
| 105 | RPS6KA5 | 0.36931545 |
| 106 | PRKD2 | 0.36715629 |
| 107 | MARK2 | 0.34671447 |
| 108 | CDK19 | 0.33644779 |
| 109 | IRAK2 | 0.33547674 |
| 110 | STK16 | 0.33474962 |
| 111 | PDGFRB | 0.32658601 |
| 112 | BRD4 | 0.32490655 |
| 113 | EGFR | 0.32478093 |
| 114 | MKNK1 | 0.31888971 |
| 115 | CDK8 | 0.31415451 |
| 116 | INSRR | 0.30449749 |
| 117 | GRK5 | 0.29489231 |
| 118 | ABL2 | 0.29186927 |
| 119 | TLK1 | 0.28333696 |
| 120 | ADRBK1 | 0.26949699 |
| 121 | TNK2 | 0.26472456 |
| 122 | STK10 | 0.26411610 |
| 123 | MAPK12 | 0.26047073 |
| 124 | IGF1R | 0.25607249 |
| 125 | INSR | 0.25421173 |
| 126 | RPS6KA6 | 0.24547995 |
| 127 | BCR | 0.23598694 |
| 128 | SGK3 | 0.22689036 |
| 129 | MAP3K12 | 0.20379838 |
| 130 | MAPK3 | 0.20075644 |
| 131 | ATR | 0.19567130 |
| 132 | MKNK2 | 0.19427475 |
| 133 | MAPK4 | 0.17715167 |
| 134 | HIPK2 | 0.17583490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.38538427 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.15537292 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.07318197 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.04492238 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.92590321 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.73873739 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.69348287 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.61113712 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.55406228 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.53781433 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.37558539 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.33521808 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.23654896 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.16015363 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 2.13698588 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.08431659 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05907604 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.04092650 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.03573765 |
| 20 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.96730367 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.94432866 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.94372214 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.83151930 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.83061316 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81966973 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.78429699 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76353096 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.71863764 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55412040 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52951989 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.41416472 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38357849 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35472257 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.34686820 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34462341 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.30081490 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25354294 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.13180201 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.11159625 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.09902927 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09452972 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.06026899 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.04322654 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96474863 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96210055 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94714937 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 0.90086505 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87171336 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85933178 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82447418 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80050387 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75107429 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70963737 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.68288325 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66293755 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65551862 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64556789 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63631140 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60185376 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59764237 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58603518 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57401758 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55573990 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55545310 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52036950 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.50855105 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47918869 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.47652894 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45621775 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44731371 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42772808 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38491958 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38299928 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.35332094 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35075726 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34112330 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33101495 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32882376 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32600816 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32270987 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31701250 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31614724 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31565673 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30402502 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29948869 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.29414375 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28677309 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28502846 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28274833 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27639904 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27403674 |
| 92 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.26516215 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26329662 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25623735 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24453584 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23193041 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.22363660 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.21834304 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | 0.21267923 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20976288 |
| 101 | Base excision repair_Homo sapiens_hsa03410 | 0.20691817 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18940790 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.18259498 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17818114 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17792781 |
| 106 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.17316311 |
| 107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.16931316 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16798110 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.15224200 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.15059782 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14714214 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.14429339 |
| 113 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.13446447 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | 0.12218916 |
| 115 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.11838953 |
| 116 | Proteasome_Homo sapiens_hsa03050 | 0.11726720 |
| 117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.11654795 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10996263 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10907363 |
| 120 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.10798221 |

